Therapeutic vaccines

Therapeutic vaccines

  • Advances in tumor profiling and antigen discovery – the role of new analytical technology and AI
  • Progress in personalized cancer vaccines
  • Optimal tumor antigen selection in cancer vaccines: establishing a tumor-specific cytotoxic T cell response
  • Selecting   an appropriate platform for cancer vaccines – nucleic acid, peptide, viral vector, etc.
  • Delivery bottlenecks limiting therapeutic vaccine expansion
  • Dosage and route of administration for optimal immune response
  • Combining cancer vaccines with cell therapies, immune checkpoint inhibitors, and chemotherapy
}